Clinical Study II:

Effect of Psilocybin on Inflammation in the Blood

Sponsored Research Agreement
University of California, San Francisco (UCSF)

Market Opportunity

Multiple Indications

  • Parkinson’s Disease, chronic pain, and bipolar disorder

Technology

  • Repeated low doses of psilocybin and ketamine

Applications

  • Examine psilocybin’s and ketamine’s effect on inflammatory activity in humans
  • Accelerate its implementation as a potential treatment for Parkinson’s Disease, chronic pain, and bipolar disorder

Get more information on Silo Pharma. Sign up for email alerts online.